STEROID FOR MANAGEMENT OF PSEUDO-OTHEMATOMA
on
Authors:
Wayan Sudana, Nyoman Adiputra, H.M.S. Wiyadi
Abstract:
“Has conducted research on the use of steroids triamsinolon asetonid as pseudo-othematomamedical therapy. The purpose of this study was to determine the effectiveness triamsinolonasetonid. Prevention of the formation of serum in the lesion, so that pseudo-othematomacan be cured without surgery. Surgery and preventing of the formation collagen tissue inthe lesion, so that the pseudo-othematoma can be cured without deformity. It is expectedthe establishment of a pseudo-othematoma practical for health personnel, effective,efficient, safe and comfortable for the patient. This study design is the design of arandomized controled pretest-postest design. In the test group were treated withtriamsinolon asetonid intracutaneus injected in lesion area with the number according tothe percentage of the amount of teraphy effusion before. Then press verban installed. In thecontrol group, only pressing verban installed. From the research results obtained, whishafter the third treatment using the triamsinolon asetonid, pseudo-othematoma diseaselooked very meaningful. Due to its unique histological structure of the ear, then themanipulation of the ear is moe advisable to be careful, to prevent new lession with variousimpacts.”
Keywords
Keyword Not Available
Downloads:
Download data is not yet available.
References
References Not Available
PDF:
https://jurnal.harianregional.com/ijbs/full-3813
Published
2021-11-09
How To Cite
SUDANA, Wayan; ADIPUTRA, Nyoman; WIYADI, H.M.S.. STEROID FOR MANAGEMENT OF PSEUDO-OTHEMATOMA.INDONESIAN JOURNAL OF BIOMEDICAL SCIENCES, [S.l.], nov. 2012. ISSN 2302-2906. Available at: https://jurnal.harianregional.com/ijbs/id-3813. Date accessed: 08 Jul. 2024.
Citation Format
ABNT, APA, BibTeX, CBE, EndNote - EndNote format (Macintosh & Windows), MLA, ProCite - RIS format (Macintosh & Windows), RefWorks, Reference Manager - RIS format (Windows only), Turabian
Issue
Vol. 5, No. 1 Januari 2011
Section
Articles
Copyright
This work is licensed under a Creative Commons Attribution 4.0 International License
Discussion and feedback